VIMTA LABS
|
The Current P/S Ratio of VIMTA LABS is 6.23.
Share Price | ₹470.9 | Jul 04,2025 |
Market Cap | ₹2,095.3 Cr | |
Sales-TTM | ₹336.1 Cr | TTM-Consolidated Results |
Price/Sales | 6.23x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of VIMTA LABS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹2,095.3 Cr] as on Jul 04,2025
(/) Sales [ ₹336.1 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 6.23x ]
Thus, for VIMTA LABS , the investors are currently willing to pay '6.23 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of VIMTA LABS !
The chart below summarizes the trend in P/S Ratio of VIMTA LABS over the last five years.
Historical PS (Price/Sales) ratio chart of VIMTA LABS
PS Ratio Performance Analysis for VIMTA LABS
- VIMTA LABS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 2.04x.
- VIMTA LABS 's operated at median p/e ratio of 2.19x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, VIMTA LABS 's p/e ratio peaked in Mar2024 at 3.1x.
- VIMTA LABS 's p/e ratio hit its five-year low in Mar2020 of 0.72x.
How does VIMTA LABS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
VIMTA LABS | 336.1 | 6.23 | 2,095.3 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 52,578.4 | 7.65 | 402,284.0 |
DIVIS LABORATORIES LTD | 9,360.0 | 19.58 | 183,268.0 |
CIPLA LTD | 27,547.6 | 4.44 | 122,253.0 |
TORRENT PHARMACEUTICALS LTD | 11,516.0 | 9.90 | 113,988.0 |
DR REDDYS LABORATORIES LTD | 32,643.9 | 3.34 | 108,921.0 |
MANKIND PHARMA LTD | 12,279.3 | 8.20 | 100,677.0 |
ZYDUS LIFESCIENCES LTD | 23,241.5 | 4.33 | 100,724.0 |
LUPIN LTD | 22,707.9 | 3.98 | 90,285.9 |
AUROBINDO PHARMA LTD | 31,723.7 | 2.18 | 69,150.2 |
ABBOTT INDIA LTD | 6,409.2 | 11.52 | 73,833.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs VIMTA LABS 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.18x |
Max industry PS | 19.58x |
Median industry PS | 6.23x |
Average industry PS | 7.39x |
You may also like the below Video Courses